83 related articles for article (PubMed ID: 23200778)
1. Selective induction of glutathione S-transferases in round spermatids from the Brown-Norway rat by the chemotherapeutic regimen for testicular cancer.
Delbès G; Chan D; Hales BF; Trasler JM; Robaire B
Reprod Toxicol; 2013 Apr; 36():24-32. PubMed ID: 23200778
[TBL] [Abstract][Full Text] [Related]
2. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.
Delbès G; Chan D; Pakarinen P; Trasler JM; Hales BF; Robaire B
Biol Reprod; 2009 Feb; 80(2):320-7. PubMed ID: 18987330
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in sperm DNA associated with testicular cancer treatment.
Chan D; Delbès G; Landry M; Robaire B; Trasler JM
Toxicol Sci; 2012 Feb; 125(2):532-43. PubMed ID: 22076425
[TBL] [Abstract][Full Text] [Related]
4. The effects of chemotherapy with bleomycin, etoposide, and cis-platinum (BEP) on rat sperm chromatin remodeling, fecundity and testicular gene expression in the progeny.
Maselli J; Hales BF; Robaire B
Biol Reprod; 2013 Oct; 89(4):85. PubMed ID: 23986570
[TBL] [Abstract][Full Text] [Related]
5. Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity.
Delbes G; Hales BF; Robaire B
J Androl; 2007; 28(2):241-9; discussion 250-1. PubMed ID: 17021337
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells.
Bagheri-Sereshki N; Hales BF; Robaire B
Biol Reprod; 2016 Apr; 94(4):81. PubMed ID: 26911428
[TBL] [Abstract][Full Text] [Related]
7. Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.
Waxman DJ; Sundseth SS; Srivastava PK; Lapenson DP
Cancer Res; 1992 Oct; 52(20):5797-802. PubMed ID: 1394205
[TBL] [Abstract][Full Text] [Related]
8. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility.
Bieber AM; Marcon L; Hales BF; Robaire B
J Androl; 2006; 27(2):189-200. PubMed ID: 16278370
[TBL] [Abstract][Full Text] [Related]
9. The effects of chemotherapy with bleomycin, etoposide, and cis-platinum on telomeres in rat male germ cells.
Liu M; Maselli J; Hales BF; Robaire B
Andrology; 2015 Nov; 3(6):1104-12. PubMed ID: 26446377
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat.
Marcon L; Hales BF; Robaire B
J Androl; 2008; 29(4):408-17. PubMed ID: 18296477
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
13. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate.
Ebert MN; Klinder A; Peters WH; Schäferhenrich A; Sendt W; Scheele J; Pool-Zobel BL
Carcinogenesis; 2003 Oct; 24(10):1637-44. PubMed ID: 12896903
[TBL] [Abstract][Full Text] [Related]
14. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
16. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
Peckham MJ; Horwich A; Blackmore C; Hendry WF
Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
[TBL] [Abstract][Full Text] [Related]
17. Paternal exposure to testis cancer chemotherapeutics alters sperm fertilizing capacity and affects gene expression in the eight-cell stage rat embryo.
Maselli J; Hales BF; Robaire B
Andrology; 2014 Mar; 2(2):259-66. PubMed ID: 24478030
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages.
Wang L; Groves MJ; Hepburn MD; Bowen DT
Haematologica; 2000 Jun; 85(6):573-9. PubMed ID: 10870112
[TBL] [Abstract][Full Text] [Related]
19. Soluble glutathione S-transferases from rat testes: isoenzyme pattern and lack of inducibility by drug metabolizing enzyme inducers.
Dierickx PJ
Toxicol Eur Res; 1982 Jan; 4(1):47-51. PubMed ID: 7112564
[TBL] [Abstract][Full Text] [Related]
20. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
